[T]he World Trade Organization reached agreement designed to facilitate the export of medicines by opening the door to a compulsory licence for developing countries…Canada became an early adopter of the agreement by reforming the Patent Act…Several years later, most agree the policy have been a near-total failure. The law has only been used once and the company involved…vowed not to repeat it…Senator Yoine Goldstein took a step toward addressing the problem by introducing Bill S-232… The bill will undoubtedly face opposition from some pharmaceutical firms…[I]t would establish a "one-licence solution" to enable generic pharmaceutical manufacturers to send shipments of the same medication to multiple countries without needing new approvals for each shipment. [refers to Apotex]